Single-use device reuse
This article was originally published in The Gray Sheet
Executive Summary
House-Senate conferees agree to language in the FY 2000 agriculture appropriations bill that would require FDA to allocate $1 mil. to study the reprocessing of single-use medical devices, conferee Sen. Richard Durbin (D-Ill.) reports Sept. 23. The provision was a part of the Senate ag approps measure but Durbin notes that conferees opted to use language from his stand-alone bill (S 1542), the "Reprocessed Single Use Medical Device Patient Safety Amendments," rather than what originally had been proposed. The conference committee has also agreed to set FDA appropriations at approximately $1.19 bil. -below the level approved by the House but above that passed by the Senate. The conference committee has stood in recess since Sept. 22, stalled by disagreements over agricultural issues. No date has been set for resuming the conference
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.